4//SEC Filing
Flex Pharma, Inc. 4
Accession 0001615219-17-000010
$SLRXCIK 0001615219operating
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 9:03 AM ET
Size
5.2 KB
Accession
0001615219-17-000010
Insider Transaction Report
Form 4
Wessel Thomas
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2017-01-18+85,000→ 85,000 totalExercise: $4.58Exp: 2027-01-18→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The stock option will vest in 48 successive equal monthly installments measured from January 18, 2017.
Documents
Issuer
Flex Pharma, Inc.
CIK 0001615219
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001615219
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 9:03 AM ET
- Size
- 5.2 KB